Arcosa Stock Price, News & Analysis (NYSE:ACA)

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ACA shares.
View ACA analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 12-month target prices for Arcosa's shares. Their ACA share price targets range from $85.00 to $90.00. On average, they anticipate the company's stock price to reach $88.00 in the next year. This suggests a possible upside of 13.2% from the stock's current price.
View analysts price targets for ACA or view top-rated stocks among Wall Street analysts.

Arcosa's stock was trading at $54.34 on January 1st, 2023. Since then, ACA shares have increased by 43.1% and is now trading at $77.77.
View the best growth stocks for 2023 here.

Arcosa saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 446,800 shares, an increase of 19.8% from the October 31st total of 373,100 shares. Based on an average trading volume of 229,800 shares, the days-to-cover ratio is currently 1.9 days. Approximately 0.9% of the company's stock are sold short.
View Arcosa's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our ACA earnings forecast.

Arcosa, Inc. (NYSE:ACA) posted its quarterly earnings results on Thursday, November, 2nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.07. The firm had revenue of $591.70 million for the quarter, compared to analyst estimates of $586.04 million. Arcosa had a net margin of 12.88% and a trailing twelve-month return on equity of 6.04%. The firm's revenue was down 2.0% compared to the same quarter last year. During the same period last year, the firm posted $0.70 EPS.

Arcosa declared a quarterly dividend on Thursday, September 7th. Investors of record on Friday, October 13th will be given a dividend of $0.05 per share on Tuesday, October 31st. This represents a $0.20 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, October 12th.
Read our dividend analysis for ACA.

Arcosa (NYSE:ACA) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.26%. The dividend payout ratio is 3.40%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ACA will have a dividend payout ratio of 5.99% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ACA.

ETFs with the largest weight of Arcosa (NYSE:ACA) stock in their portfolio include ProShares S&P Kensho Cleantech ETF (CTEX), First Trust RBA American Industrial Renaissance ETF (AIRR), SPDR S&P Kensho Clean Power ETF (CNRG), Invesco S&P SmallCap Industrials ETF (PSCI), Nuveen Small Cap Select ETF (NSCS), Opus Small Cap Value Plus ETF (OSCV), First Trust Global Wind Energy ETF (FAN) and Invesco S&P SmallCap Momentum ETF (XSMO).

15 employees have rated Arcosa Chief Executive Officer Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among the company's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Arcosa's stock is owned by a number of institutional and retail investors. Top institutional investors include Loomis Sayles & Co. L P (2.11%), Morgan Stanley (1.40%), Northern Trust Corp (1.33%), Charles Schwab Investment Management Inc. (1.23%), The Manufacturers Life Insurance Company (1.20%) and Bank of New York Mellon Corp (0.98%). Insiders that own company stock include Antonio Carrillo, Bryan Stevenson, Gail M Peck, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends.

Shares of ACA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.